SCHEMBL27409296

SCHEMBL27409296

CC(C)(CCOC(C)(C)CCn1cc(CNC(=O)CCCC#Cc2cnc(S(C)(=O)=O)nc2)nn1)NC(=O)COCC(=O)NCC(=O)Nc1ccc(CO)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22561301 0.83 — —
SCHEMBL27410348 0.79 CA1 (0.33) —
SCHEMBL29293332 0.74 — —
SCHEMBL23193195 0.74 OPRM1 (0.34) —
SCHEMBL27409838 0.73 FOLH1 (0.31) —
SCHEMBL27410347 0.73 FOLH1 (0.32) —
SCHEMBL22561332 0.73 — —
SCHEMBL22561439 0.72 — —
SCHEMBL22561326 0.72 — —
SCHEMBL27189806 0.70 FOLH1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024123914-A1 PROCESS FOR MAKING ANTIBODY-DRUG CONJUGATES MERCK SHARP & DOHME LLC (US) 2024-06-13 — — WO disclosed
Send feedback